The Liver Meeting® 2019 ePosters: Liver Fibrogenesis and Non-Parenchymal Cell Biology
-
1444: CPEB4-DRIVEN PFKFB3-MEDIATED METABOLIC REPROGRAMMING IS ESSENTIAL FOR HEPATIC STELLATE CELL ACTIVATION AND LIVER FIBROSIS: A NOVEL DRUGGABLE TARGETAuthors: Mercedes Fernandez, Marc Mejias, Javier Gallego, Salvador Naranjo-Suarez, Marta Ramirez, Nuria Pell, Anna Manzano, Ramon Bartrons, Raul MendezYou must log in to access content.
-
1463: POST-TRANSLATIONAL MODIFICATIONS DRIVE THE EFFECTS OF HIGH-MOBILITY GROUP BOX-1 DURING LIVER FIBROSIS PROGRESSION AND RESOLUTIONAuthors: Xiaodong Ge, Romain Desert, Elena Arriazu, Fernando Magdaleno Verduzco, Daniel Lantvit, Daniel Antoine, Hui Chen, Natalia NietoYou must log in to access content.
-
1467: Galectin3 INHIBITOR X2 ALLEVIATES LIVER FIBROSIS VIA SURPPRESSION OF INFLAMMATION AND HEPATIC STELLATE CELLS ACTIVATIONAuthors: Yi Zang, Guanzhen Wang, Kan DingYou must log in to access content.
-
1468: ARYL HYDROCARBON RECEPTOR SIGNALING PREVENTS ACTIVATION OF HEPATIC STELLATE CELLS AND LIVER FIBROGENESIS IN MICEAuthors: Jiong Yan, Hung-Chun Tung, Wen Xie, Sihan Li, Da YangYou must log in to access content.
-
1473: MODELLING LIVER MOLECULAR FIBROGENESIS IN HUMAN LIVER SLICES CULTUREAuthors: Daria Kartasheva-Ebertz, Jesintha Gaston, Loriane Lair-Mehiri, Pierre-Philippe Massault, Olivier Scatton, Jean-Christophe Vaillant, Vladimir A. Morozov, Stanislas Pol, Sylvie LagayeYou must log in to access content.
-
1478: THERMO-RESPONSIVE HUMAN LIVER EXTRACELLULAR MATRIX THREE-DIMENSIONAL HYDROGELS FOR MODELLING LIVER FIBROSISAuthors: Maria Giovanna Vilia, Elisabetta Caon, Denis Cecchin, Giuseppe Battaglia, Giuseppe Mazza, Luca Frenguelli, Walid Al-Akkad, Massimo Pinzani, Krista RomboutsYou must log in to access content.
-
1479: IMPACT OF TRANSITION FROM PROTEOLYTIC TO INTEGRIN-ASSOCIATED TGF-ΒETA ACTIVATION DURING LIVER FIBROSIS IN A NASH MODELAuthors: Soichi Kojima, Xian-Yang Qin, Ikuyo Inoue, Hiroshi Yokoyama, Takahiro Masaki, Tomokazu MatsuuraYou must log in to access content.
-
1482: CM-101 A NOVEL CCL24 BLOCKING MONOCLONAL ANTIBODY ATTENUATES HSC ACTIVATION IN VITRO AND REDUCES FIBROSIS IN THE TAA MICE MODELAuthors: Adi Mor, Neta Barashi, Avi Katav, Victoria Edelshtein, Michal Segal Salto, Arnon AharonYou must log in to access content.
-
1864: PATIENT-REPORTED OUTCOMES (PROs) IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND COMPENSATED CIRRHOSIS (CC): DATA FROM THE STELLAR-4 PHASE 3 CLINICAL TRIALAuthors: Maria Stepanova, Zobair Younossi, Fatema Nader, Manuel Romero-Gomez, Takeshi Okanoue, Michael Trauner, Robert Myers, Stephen Djedjos, Stephen Harrison, Zachary GoodmanYou must log in to access content.
-
1867: THE ROLE OF COLLAGEN NEO-EPITOPE BIOMARKERS IN PREDICTING ADVANCED HISTOLOGIC FIBROSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)Authors: Azza Karrar, Zobair Younossi, Thomas Jeffers, Sean Felix, Brian Lam, Maria Stepanova, Samuel Hellings, Elizabeth Brown, Yi Luo, Anthony Sanfiz, Leonid Zhelnin, Edgar Charles, Sumanta Mukherjee, Lei Zhao, David Gordon, Fatema Nader, Zachary Goodman, John ThompsonYou must log in to access content.
-
1874: HIGH LEVELS OF TROPONIN I ARE ASSOCIATED WITH LIVER FIBROSIS IN NONALCOHOLIC STEATOHEPATITIS (NASH)Authors: Aybike Birerdinc, Zobair Younossi, Azza Karrar, Lynn Gerber, Andrei Racila, Henry Tran, Elzafir Elsheikh, James Paik, Sean Felix, Thomas Jeffers, Zahra Younoszai, Brian Lam, Zachary GoodmanYou must log in to access content.
-
1876: THE HEPATIC NATURAL KILLER CELLS NKG2D DOWN-REGULATED IN CHB-RELATED LIVER CIRRHOSISAuthors: Xin Sun, Chenghai Liu, Dabing Ping, Yuan Peng, Feng Xing, Yanyan TaoYou must log in to access content.
-
1877: NANOPARTICULAR BISPHOSPHONATE TO SELECTIVELY TARGET AND REPOLARIZE LIVER MACROPHAGES FOR ANTI-FIBROTIC RESPONSES IN experimental LIVER FIBROSISAuthors: Leonard Kaps, Lutz Nuhn, Niklas Choteschovsky, Adrian Klefenz, Misbah Aslam, Rudolf Zentel, Detlef SchuppanYou must log in to access content.
-
1878: SITAGLIPTIN USE IN A LARGE COHORT OF CHRONIC HEPATITIS B WITH CONCOMITANT DIABETES WAS ASSOCIATED WITH INCREASED RISK OF SEVERE LIVER FIBROSISAuthors: Wai-Kay Seto, Hei-Chun Justin Ma, Ka Shing Cheung, Chi Ho Lee, Lung Yi Mak, James Fung, Ching Lung Lai, Man Fung YuenYou must log in to access content.
-
1880: USEFULNESS OF ENDOSCOPIC ULTRASONOGRAPHY ELASTOGRAPHY (EUS-E) TO MEASURE LIVER STIFFNESSAuthors: Yesim Alahdab, Coskun Demirtas, Deniz Guney Duman, Yusuf Yilmaz, Feyza GunduzYou must log in to access content.
-
2085: CAN NON-INVASIVE TESTS (NIT) DETECT CHANGES IN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) IN PATIENTS WITH HEPATITIS C (HCV) COMPENSATED CIRRHOSIS?Authors: Guillermo Ortiz, Arpan Mohanty, Mubarak Sayyar, Parastoo Jangouk, Gowthaman Gunabushanam, Campbell Sheldon, Yanhong Deng, Maria Ciarleglio, Guadalupe Garcia-TsaoYou must log in to access content.
-
2086: A SEROLOGICAL miRNA-BASED ALGORITHM (MIRFIB) FOR THE IDENTIFICATION OF SIGNIFICANT LIVER FIBROSIS IN PATIENTS WITH CHRONIC ALCOHOL ABUSE, NAFLD, AND VIRAL LIVER DISEASEAuthors: Hendrik Reynaert, Joeri Lambrecht, Stefaan Verhulst, Leo A Van GrunsvenYou must log in to access content.
-
2090: LIVER STIFFNESS MEASUREMENT BY MAGNETIC RESONANCE ELASTOGRAPHY PREDICTS FUTURE DEVELOPMENT OF CIRRHOSIS AND DECOMPENSATIONAuthors: Tolga Gidener, Omar Ahmed, Joseph Larson, Terry Therneau, Bogdan Dzyubak, Sudhakar Venkatesh, Richard Ehman, Meng Yin, Alina AllenYou must log in to access content.
-
2092: NGM282, AN FGF19 ANALOGUE, REDUCES NET DEPOSITION OF COLLAGEN III IN NON-ALCOHOLIC STEATOHEPATITIS AND PRIMARY SCLEROSING CHOLANGITISAuthors: Stephen Harrison, Lei Ling, Mette Nielsen, James Trotter, Angelo Paredes, Andrew Yan, Ulrich Beuers, Gideon Hirschfield, Diana Leeming, Morten Karsdal, Alex DePaoliYou must log in to access content.
-
2098: SMALL LIVER VOLUMES: CAUSE AND SIGNIFICANCEAuthor: John HoefsYou must log in to access content.
Access Date | Quiz Result | Score | Actions |
---|